Fabián Santana-Romo

Dr. Fabián Santana-Romo

Departamento de Ciencias Exactas, Universidad de las Fuerzas Armadas ESPE, Sangolquí, Pichincha, Ecuador
orcid
Chemistry PhD.

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Fabián Santana-RomoFabián Santana-Romo
Fabián Santana-Romo
CLCarlos F. Lagos
Carlos F. Lagos
YAYorley Andrea Duarte Ayala
Yorley Andrea Duarte Ayala
FCFrancisco Castillo
Francisco Castillo
YMYanina Moglie
Yanina Moglie
FZFlavia Zacconi
Flavia Zacconi
The coagulation cascade is the process of the conversion of soluble fibrinogen to insoluble fibrin that terminates in production of a clot. Factor Xa (FXa) is a serine protease involved in the blood coagulation cascade. Moreover, FXa plays a vital role in the enzymatic sequence which ends with the thrombus production. Thrombosis is a common causal pathology for three widespread cardiovascular syndromes: acute coronary syndrome (ACS), venous thromboembolism (VTE), and strokes. In this research a series of N-propargyltetrahydroquinoline and 1,2,3-triazole derivatives as a potential factor Xa (FXa) inhibitor were designed, synthesized, and evaluated for their FXa inhibitor activity, cytotoxicity activity and coagulation parameters. Rational design for the desired novel molecules was performed through protein-ligand complexes selection and ligand clustering. The microwave-assisted synthetic strategy of selected compounds was carried out by using Ullmann-Goldberg, N-propargylation, Mannich addition, Friedel-Crafts, and 1,3-dipolar cycloaddition type reactions under microwave irradiation. The microwave methodology proved to be an efficient way to obtain all novel compounds in high yields (73–93%). Furthermore, a thermochemical analysis, optimization and reactivity indexes such as electronic chemical potential (µ), chemical hardness (η), and electrophilicity (ω) were performed to understand the relationship between the structure and the energetic behavior of all the series. Then, in vitro analysis showed that compounds 27, 29–31, and 34 exhibited inhibitory activity against FXa and the corresponding half maximal inhibitory concentration (IC50) values were calculated. Next, a cell viability assay in HEK293 and HepG2 cell lines, and coagulation parameters (anti FXa, Prothrombin time (PT), activated Partial Thromboplastin Time (aPTT)) of the most active novel molecules were performed to determine the corresponding cytotoxicity and possible action on clotting pathways. The obtained results suggest that compounds 27 and 29 inhibited FXa targeting through coagulation factors in the intrinsic and extrinsic pathways. However, compound 34 may target coagulation FXa mainly by the extrinsic and common pathway. Interestingly, the most active compounds in relation to the inhibition activity against FXa and coagulation parameters did not show toxicity at the performed coagulation assay concentrations. Finally, docking studies confirmed the preferential binding mode of N-propargyltetrahydroquinoline and 1,2,3-triazole derivatives inside the active site of FXa.

27 August 2019 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
NNNicolás E. Núñez-Navarro
Nicolás E. Núñez-Navarro
Fabián Santana-RomoFabián Santana-Romo
Fabián Santana-Romo
LPLoreto P. Parra
Loreto P. Parra
FZFlavia Zacconi
Flavia Zacconi
Factor Xa (FXa) plays a key role in haemostasis, it is a central part of the blood coagulation cascade which catalyzes the production of thrombin and leads to clot formation and wound closure. Therefore, FXa is an attractive target for the development of new anticoagulant agents. In this review, we will first describe the molecular features of this fundamental protein in order to understand its mechanism of action, an essential background for the design of novel inhibitors by means of synthetic organic chemistry or using peptides obtained from recombinant methodologies. Then, we will review the current state of the synthesis of novel direct FXa inhibitors along with their mechanisms of action. Finally, approved reversal agents that aid in maintaining blood haemostasis by using these commercial drugs will also be discussed.

31 March 2025 in Industrial Crops and Products
Verified
Journal Article
Open access
CACristina Almeida
Cristina Almeida
Fabián Santana-RomoFabián Santana-Romo
Fabián Santana-Romo
EGElvia Gallegos-Castro
Elvia Gallegos-Castro
Cristina VillamarCristina Villamar
Cristina Villamar
Alexis DebutAlexis Debut
Alexis Debut

1 November 2021 in Annals of Hepatology
Verified
Journal Article
Open access
AXAline Xavier
Aline Xavier
FZFlavia Zacconi
Flavia Zacconi
Fabián Santana-RomoFabián Santana-Romo
Fabián Santana-Romo
TEThomas R. Eykyn
Thomas R. Eykyn
BLBegoña Lavin
Begoña Lavin
MAMarcelo E. Andia
Marcelo E. Andia
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver abnormalities including steatosis, steatohepatitis, fibrosis, and cirrhosis. Liver biopsy remains the gold standard method to determine the disease stage in NAFLD but is an invasive and risky procedure. Studies have previously reported that changes in intrahepatic fatty acids (FA) composition are related to the progression of NAFLD, mainly in its early stages. The aim of this study was to characterize the liver FA composition in mice fed a Choline-deficient L-amino-defined (CDAA) diet at different stages of NAFLD using magnetic resonance spectroscopy (MRS). We used in-vivo MRS to perform a longitudinal characterization of hepatic FA changes in NAFLD mice for 10 weeks. We validated our findings with ex-vivo MRS, gas chromatography-mass spectrometry and histology. In-vivo and ex-vivo results showed that livers from CDAA-fed mice exhibit a significant increase in liver FA content as well as a change in FA composition compared with control mice. After 4 weeks of CDAA diet, a decrease in polyunsaturated and an increase in monounsaturated FA were observed. These changes were associated with the appearance of early stages of steatohepatitis, confirmed by histology (NAFLD Activity Score (NAS) = 4.5). After 10 weeks of CDAA-diet, the liver FA composition remained stable while the NAS increased further to 6 showing a combination of early and late stages of steatohepatitis. Our results suggest that monitoring lipid composition in addition to total water/fat with MRS may yield additional insights that can be translated for non-invasive stratification of high-risk NAFLD patients.

18 December 2023 in Synthesis
Verified
Journal Article
Closed access
PDF file
RORomina Andrea Ocampo
Romina Andrea Ocampo
SMSandra Delia Mandolesi
Sandra Delia Mandolesi
FLFernando Javier Lorenzo
Fernando Javier Lorenzo
DRDiego F. Rodríguez
Diego F. Rodríguez
Fabián Santana-RomoFabián Santana-Romo
Fabián Santana-Romo
NDNorma Beatriz D'Accorso
Norma Beatriz D'Accorso
Using a chemoselective, sustainable and highly efficient method, new 4-thiazolidinones and 1,4-thiazepan-3-ones substituted with a glycosidic residue derived from d-fructose were synthesized. Microwave-assisted cascade multicomponent reaction under solvent-free conditions gave very good yields in short reaction times, which was followed by a nontoxic purification method of one of the diastereomers by precipitation–centrifugation. The new purified compounds isolated as diastereomers were evaluated as factor Xa (FXa) inhibitors.

13 April 2024 in Molecules
Verified
Journal Article
Open access
PDF file
RDRocío Belén Durán
Rocío Belén Durán
CBCésar Barrales-Martínez
César Barrales-Martínez
Fabián Santana-RomoFabián Santana-Romo
Fabián Santana-Romo
DRDiego Rodriguez
Diego Rodriguez
FZFlavia Zacconi
Flavia Zacconi
BHBarbara Herrera
Barbara Herrera
In this article, we present a comprehensive computational investigation into the reaction mechanism of N-arylation of substituted aryl halides through Ullmann-type coupling reactions. Our computational findings, obtained through DFT ωB97X-D/6-311G(d,p) and ωB97X-D/LanL2DZ calculations, reveal a direct relation between the previously reported experimental reaction yields and the activation energy of haloarene activation, which constitutes the rate-limiting step in the overall coupling process. A detailed analysis of the reaction mechanism employing the Activation Strain Model indicates that the strain in the substituted iodoanilines is the primary contributor to the energy barrier, representing an average of 80% of the total strain energy. Additional analysis based on conceptual Density Functional Theory (DFT) suggests that the nucleophilicity of the nitrogen in the lactam is directly linked to the activation energies. These results provide valuable insights into the factors influencing energetic barriers and, consequently, reaction yields. These insights enable the rational modification of reactants to optimize the N-arylation process.